openPR Logo
Press release

ANCA Vasculitis Pipeline Drugs, FDA Approvals, and Companies 2024

08-26-2024 03:06 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

ANCA Vasculitis Pipeline

ANCA Vasculitis Pipeline

DelveInsight's, "ANCA Vasculitis Pipeline Insight 2024" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in ANCA Vasculitis pipeline landscape. It covers the ANCA Vasculitis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the ANCA Vasculitis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Explore our latest breakthroughs in ANCA Vasculitis Research. Learn more about our innovative pipeline today! @ ANCA Vasculitis Pipeline Outlook- https://www.delveinsight.com/sample-request/anca-vasculitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the ANCA Vasculitis Pipeline Report
• June 2024:- Amgen- A Randomized, Double-blind, Placebo-controlled Phase 4 Clinical Trial to Evaluate the Long-term Safety and Efficacy of Avacopan in Subjects With Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis. The primary objective of this study is to evaluate the long-term safety of avacopan in participants with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
• June 2024:- Alpine Immune Sciences Inc.- An Open-Label, Multiple-Ascending Dose Study to Assess the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Different Dose Levels of Povetacicept in Subjects With Autoantibody-Associated Glomerular Diseases (RUBY-3). The goal of this clinical study is to evaluate multiple dose levels of povetacicept (ALPN-303) in adults with immunoglobulin A (IgA) nephropathy, membranous nephropathy, lupus-related kidney disease (lupus nephritis). or anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis to determine if povetacicept is safe and potentially beneficial in treating these diseases.
• DelveInsight's ANCA Vasculitis pipeline report depicts a robust space with 12+ active players working to develop 12+ pipeline therapies for ANCA Vasculitis treatment.
• The leading ANCA Vasculitis Companies such as Bristol-Myers Squibb, Travere Therapeutics, Novartis Pharmaceuticals, NS Pharma, Staidson Biopharmaceuticals Co., Ltd., and others.
• Promising ANCA Vasculitis Therapies such as BDB-001 injection, Cyclophosphamide, Glucocorticoids, Avacopan, Iptacopan, NM8074, and others.

Stay informed about the cutting-edge advancements in ANCA Vasculitis Treatments. Download for updates and be a part of the revolution in Cardiovascular Diseases care @ ANCA Vasculitis Clinical Trials Assessment- https://www.delveinsight.com/sample-request/anca-vasculitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

ANCA Vasculitis Emerging Drugs Profile
• Abatacept: Bristol-Myers Squibb
Abatacept is a selective T-cell co-stimulation modulator. Abatacept binds to CD80 and CD86 receptors on antigen-presenting cells (APCs), which are essential for T-cell activation. This binding blocks the interaction between CD80/CD86 and CD28, thereby inhibiting the delivery of the second co-stimulatory signal required for optimal T-cell activation. Currently, the drug is in Phase III stage of its clinical trial for the treatment of ANCA Vasculitis.

• Sparsentan : Travere Therapeutics
Sparsentan is a dual endothelin and angiotensin II receptor antagonist used to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression. Sparsentan acts as a dual antagonist of the endothelin type A receptor (ETAR) and the angiotensin II type 1 receptor (AT1R), which are involved in the pathogenesis of IgAN. It selectively blocks the action of endothelin-1 (ET-1) and angiotensin II (Ang II) at their respective receptors, thereby reducing proteinuria. The drug is currently in Phase II of clinical trial evaluation for the treatment of ANCA Associated Vasculitis.

Learn more about ANCA Vasculitis Drugs opportunities in our groundbreaking ANCA Vasculitis Research and development projects @ ANCA Vasculitis Unmet Needs- https://www.delveinsight.com/sample-request/anca-vasculitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

ANCA Vasculitis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration
• Oral
• Intravenous
• Subcutaneous
• Parenteral
• Topical

ANCA Vasculitis Products have been categorized under various Molecule types such as
• Recombinant fusion proteins
• Small molecule
• Monoclonal antibody
• Peptide
• Polymer
• Gene therapy

Discover the latest advancements in ANCA Vasculitis Treatment by visiting our website. Stay informed about how we're transforming the future of cardiovascular disease @ ANCA Vasculitis Market Drivers and Barriers, and Future Perspectives- https://www.delveinsight.com/sample-request/anca-vasculitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the ANCA Vasculitis Pipeline Report
• Coverage- Global
• ANCA Vasculitis Companies- Bristol-Myers Squibb, Travere Therapeutics, Novartis Pharmaceuticals, NS Pharma, Staidson Biopharmaceuticals Co., Ltd., and others.
• ANCA Vasculitis Therapies- BDB-001 injection, Cyclophosphamide, Glucocorticoids, Avacopan, Iptacopan, NM8074, and others.
• ALK-positive Non-Small Cell Lung Cancer Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• ALK-positive Non-Small Cell Lung Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

For a detailed overview of our latest research findings and future plans, read the full details of ANCA Vasculitis Pipeline on our website @ ANCA Vasculitis Drugs and Companies- https://www.delveinsight.com/sample-request/anca-vasculitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Introduction
2. Executive Summary
3. ANCA Vasculitis: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. ANCA Vasculitis - DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. Abatacept: Bristol-Myers Squibb
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II)
11. Sparsentan: Travere Therapeutics
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I/II)
14. Drug name: Company name
15. Drug profiles in the detailed report…..
16. Preclinical and Discovery Stage Products
17. Drug name: Company name
18. Drug profiles in the detailed report…..
19. Inactive Products
20. ANCA Vasculitis Key Companies
21. ANCA Vasculitis Key Products
22. ANCA Vasculitis- Unmet Needs
23. ANCA Vasculitis- Market Drivers and Barriers
24. ANCA Vasculitis- Future Perspectives and Conclusion
25. ANCA Vasculitis Analyst Views
26. ANCA Vasculitis Key Companies
27. Appendix

List of Top Selling Market Research Reports in 2024

Surgical Energy Generators Market- https://www.delveinsight.com/report-store/surgical-energy-generators-market
Surgical Sealant Tissue Patch Market- https://www.delveinsight.com/report-store/surgical-sealant-tissue-patch-market
Surgical Stapling Devices Market- https://www.delveinsight.com/report-store/surgical-stapling-devices-market
Vital Sign Monitoring Devices Market- https://www.delveinsight.com/report-store/vital-sign-monitors-external-remote-patient-monitoring-devices-market
Syphilis Market- https://www.delveinsight.com/report-store/syphilis-market
Vitreoretinal Surgery Devices Market- https://www.delveinsight.com/report-store/vitreoretinal-surgery-devices-market
Pelvic Organ Prolapse Market- https://www.delveinsight.com/report-store/pelvic-organ-prolapse-market
Scoliosis Market- https://www.delveinsight.com/report-store/scoliosis-market
SGLT2 Inhibitors Market- https://www.delveinsight.com/report-store/sglt2-inhibitors-market
Urinary Catheters Market- https://www.delveinsight.com/report-store/urinary-catheters-market
Carcinoid Syndrome Market- https://www.delveinsight.com/report-store/carcinoid-syndrome-market
Cardiac Monitoring Devices Market- https://www.delveinsight.com/report-store/cardiac-monitoring-devices-market
Varicose Vein Treatment Devices Market- https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
Bone Growth Stimulators Market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Skin Neoplasms Market- https://www.delveinsight.com/report-store/skin-neoplasms-market
Thrombectomy Devices Market- https://www.delveinsight.com/report-store/thrombectomy-devices-market
Novel Drug Delivery Devices Market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Lymphedema Market- https://www.delveinsight.com/report-store/lymphedema-market
Artificial Disc Market- https://www.delveinsight.com/report-store/artificial-disc-market
Exocrine Pancreatic Insufficiency Market- https://www.delveinsight.com/report-store/exocrine-pancreatic-insufficiency-epi-market
Fabry Disease Market- https://www.delveinsight.com/report-store/fabry-disease-market
Overactive Bladder Market- https://www.delveinsight.com/report-store/overactive-bladder-oab-market
Total Knee Arthroplasty Market- https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Hip Replacement Devices Market- https://www.delveinsight.com/report-store/hip-reconstruction-devices-market
Lactose Intolerance Market- https://www.delveinsight.com/report-store/lactose-intolerance-market
HDAC Inhibitors Market- https://www.delveinsight.com/report-store/hdac-inhibitors-market
Ventral Hernia Market- https://www.delveinsight.com/report-store/ventral-hernia-market
Facial Lines Market- https://www.delveinsight.com/report-store/facial-lines-market
Medical Marijuana Market- https://www.delveinsight.com/report-store/medical-marijuana-market-insight
Microscopy Device Market- https://www.delveinsight.com/report-store/microscopy-device-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Yash Bhardwaj
info@delveinsight.com
+91-9650213330

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release ANCA Vasculitis Pipeline Drugs, FDA Approvals, and Companies 2024 here

News-ID: 3634998 • Views:

More Releases from DelveInsight Business Research LLP

Urinary Tract Obstruction Treatment Devices Market Dynamics 2032: Research Trends, Commercialization Strategies, and Industry Shifts
Urinary Tract Obstruction Treatment Devices Market Dynamics 2032: Research Trend …
DelveInsight's Urinary Tract Obstruction Treatment Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Urinary Tract Obstruction Treatment Devices Companies market shares, challenges, Urinary Tract Obstruction Treatment Devices Market Drivers, barriers, trends, and key market Urinary Tract Obstruction Treatment Devices companies in the market. To read more about the latest highlights related to the Urinary Tract Obstruction Treatment Devices Market, get a snapshot of the key
DelveInsight's Portable Ultrasound Bladder Scanner Market Report 2032: In-Depth Analysis of Challenges, Opportunities, and Key Players
DelveInsight's Portable Ultrasound Bladder Scanner Market Report 2032: In-Depth …
DelveInsight's Portable Ultrasound Bladder Scanner Market Insights Report 2032 provides the current and forecast market analysis, individual leading Portable Ultrasound Bladder Scanner Companies market shares, challenges, Portable Ultrasound Bladder Scanner Market Drivers, barriers, trends, and key market Portable Ultrasound Bladder Scanner companies in the market. To read more about the latest highlights related to the Portable Ultrasound Bladder Scanner Market, get a snapshot of the key highlights entailed in the Market
Disposable Endoscopes Market Report 2032: Key Market Drivers, Competitive Landscape, and Growth Opportunities
Disposable Endoscopes Market Report 2032: Key Market Drivers, Competitive Landsc …
DelveInsight's Disposable Endoscopes Market Insights Report 2032 provides the current and forecast market analysis, individual leading Disposable Endoscopes Companies market shares, challenges, Disposable Endoscopes Market Drivers, barriers, trends, and key market Disposable Endoscopes companies in the market. To read more about the latest highlights related to the Disposable Endoscopes Market, get a snapshot of the key highlights entailed in the Market Report @ Disposable Endoscopes Market Size- https://www.delveinsight.com/sample-request/disposable-endoscopes-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from
DelveInsight's Comprehensive Analysis of the Venous Thromboembolism Treatment Devices Market: Size, Share, and Strategic Developments
DelveInsight's Comprehensive Analysis of the Venous Thromboembolism Treatment De …
DelveInsight's Venous Thromboembolism Treatment Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Venous Thromboembolism Treatment Devices Companies market shares, challenges, Venous Thromboembolism Treatment Devices Market Drivers, barriers, trends, and key market Venous Thromboembolism Treatment Devices companies in the market. To read more about the latest highlights related to the Venous Thromboembolism Treatment Devices Market, get a snapshot of the key highlights entailed in the Market

All 5 Releases


More Releases for ANCA

ANCA Vasculitis Drug Market Overview: Growth, Share, Value, Size, and Scope
The global ANCA Vasculitis Drug Market was valued at approximately USD 1.2 billion in 2023 and is projected to reach around USD 2.3 billion by 2033, growing at a CAGR of 6.5% from 2024 to 2033. ANCA Vasculitis Drug Market Overview The ANCA Vasculitis Drug Market is witnessing steady growth due to increasing awareness, earlier diagnosis, and improved treatment approaches for this rare autoimmune condition. ANCA-associated vasculitis, which includes granulomatosis with polyangiitis
ANCA Vasculitis Market to Rise by 2032 | AstraZeneca, GlaxoSmithKline, Travere T …
DelveInsight's "ANCA Vasculitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of ANCA Vasculitis, historical and forecasted epidemiology as well as the ANCA Vasculitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The ANCA Vasculitis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted ANCA Vasculitis market size
ANCA Vasculitis Clinical Trials, Pipeline Insights, Treatment Drugs, and Compani …
DelveInsight's, "ANCA Vasculitis Pipeline Insight 2024" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in ANCA Vasculitis pipeline landscape. It covers the ANCA Vasculitis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the ANCA Vasculitis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our latest breakthroughs in ANCA Vasculitis
ANCA Vasculitis Market to Reach US$ 534.3 Million by 2034
Market Overview: The ANCA vasculitis market reached a value of US$ 339.0 Million in 2023 and expected to reach US$ 534.3 Million by 2034, exhibiting a growth rate (CAGR) of 4.22% during 2024-2034. The report offers a comprehensive analysis of the ANCA vasculitis market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market,
ANCA Vasculitis Market to Reach US$ 534.3 Million by 2034
Market Overview: The ANCA vasculitis market reached a value of US$ 339.0 Million in 2023 and expected to reach US$ 534.3 Million by 2034, exhibiting a growth rate (CAGR) of 4.22% during 2024-2034. The report offers a comprehensive analysis of the ANCA vasculitis market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market,
ANCA Vasculitis Market to Witness Growth by 2032 | Estimates DelveInsight
DelveInsight's "ANCA Vasculitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of ANCA Vasculitis, historical and forecasted epidemiology as well as the ANCA Vasculitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The ANCA Vasculitis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted ANCA Vasculitis market size